Conclusively, this study indicates activation of RTKs (EGFR, PDGFRA, NTRK3), mTOR (RPS6KA3, PRKAA1) signalling, and numerous other potential candidate genes involved in neuronal survival and neuronal migration in FCD type II patients. The gene discussed is RPS6KA3; the disease is isolated focal cortical dysplasia type II.